This conference is jointly sponsored by the Karolinska Institutet (Sweden) and the Alzheimer's Drug Discovery Foundation, and is a unique venue for addressing issues related to the economic evaluation of drug treatments for Alzheimer's disease.
Leading experts and opinion leaders from academia, regulatory bodies and the pharmaceutical industry will present the latest advances and challenges in finding effective treatments for the disease.
More information may be found at www.trippus.se/eventus/eventus_cat.asp?eventusCat_id=17817&c=55567855676150492F39636F513054397965434E754C3452646C7568755647485A6F76733665375A4C796A4368722F6967425879594F534B434D437633305076 .
Email: gunilla [dot] johansson [ at ] ki [dot] se
|6th IPECAD Agenda.pdf ||204.83 KB|